Timika Tuberculosis Clinic and Community Hospital
Welcome,         Profile    Billing    Logout  
 16 Trials 
3 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kelly, Paul M
DASL-HiCaP, NCT04136353: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate

Active, not recruiting
3
1100
Europe, Canada, US, RoW
Darolutamide, Placebo oral tablet, Luteinizing Hormone-Releasing Hormone Analog, External Beam Radiotherapy
University of Sydney, Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Bayer, Cancer Trials Ireland, Canadian Cancer Trials Group, Memorial Sloan Kettering Cancer Center, Prostate Cancer Clinical Trials Consortium
Prostate Cancer
01/28
07/28
SABRE, NCT04905069: Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy

Recruiting
N/A
500
Europe, US, RoW
SpaceOAR Vue System
Boston Scientific Corporation
Prostate Cancer
04/27
04/30
Morris, Peter
NCT05496868 / 2022-001612-25: Add-on Reparixin in Adult Patients With ARDS

Recruiting
2
66
Europe, US
Reparixin 600mg, REP, Matching Placebo, Control
Dompé Farmaceutici S.p.A, Dompè farmaceutici s.p.a.
Acute Respiratory Distress Syndrome, Adult
08/25
08/25
Anstey, Nicholas M
No trials found
Ralph, Anna P
No trials found
Thio, Franciscus
No trials found
Kenangalem, Enny
No trials found
Poespoprodjo, Jeanne R
No trials found
Woodberry, Tonia
No trials found
Sandjaja, Sandjaja
No trials found
Lolong, Dina B
No trials found
Chatfield, Mark
No trials found
Bastian, Ivan
No trials found

Download Options